Doctors test re-engineered immune cells to fight early lung cancer
NCT ID NCT07498439
Summary
This early-stage study is testing the safety of a personalized immune cell therapy for people with multiple early-stage lung cancer tumors. Doctors will collect a patient's own tumor-fighting immune cells, grow them in a lab, and then inject them back into the patient. The main goal is to see if this treatment is safe and to gather early information on whether it helps control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY EARLY-STAGE NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.